By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


Glenmark Pharmaceuticals 

B/2 & 801-805, Mahalaxmi Chambers
22, Bhulabhai Desai Road
Mumbai    400 026  India
Phone: 91-0-4964893 Fax: 91-0-4932648



Company News
Sources Reveal Glenmark Pharma, Sun Pharma (SUNPHARMA.NS), Cipla (CIPLA) are Exploring Bids Worth $500-800 Million for Teva (TEVA)'s Generics Products Portfolio 11/19/2015 6:54:02 AM
Sanofi (SNY) Walks Away from a $613 Million Multiple Sclerosis Pact with Glenmark Pharma 10/30/2015 6:48:43 AM
Jaguar Animal Health Signs Crofelemer Manufacturing & Supply Agreement With Glenmark Pharmaceuticals 9/28/2015 2:07:15 PM
Glenmark Pharmaceuticals's Bi-Specific Antibody - GBR 1302 To Enter Phase I Trials 9/15/2015 5:55:41 AM
Glenmark Pharmaceuticals's Novel Monoclonal Antibody GBR 830 To Enter Phase 2 Clinical Studies In Atopic Dermatitis And Celiac Disease In US And Europe 9/3/2015 6:50:18 AM
Glenmark Pharmaceuticals Selects Life Science Industry's "Gold Standard" For Enterprise Revenue Management From Model N 8/7/2015 10:45:45 AM
Eisai Inc. (ESALF.PK) And Glenmark Pharmaceuticals Reach Settlement Over Generic Version Of BANZEL (rufinamide) 4/30/2015 11:22:46 AM
Glenmark Pharmaceuticals's Goa And Nashik Facilities Conferred The Prestigious Greentech Environment Gold Award - 2015 2/24/2015 9:59:24 AM
Glenmark Pharmaceuticals's TRPA1 Antagonist 'GRC 17536' Shows Positive Data In A Proof Of Concept Study 9/17/2014 9:34:26 AM
Glenmark Pharmaceuticals Enters Oncology With The Discovery And Initiation Of IND Enabling Studies Of An Innovative Bispecific Antibody 8/20/2014 7:38:17 AM